BPC-157, or Body Protection Compound-157 , is a synthetic peptide derived from a protein found in gastric juices
In Phase 3 TRIUMPH-1 data, diarrhea was reported in 25.2% to 34.1% of participants taking retatrutide, constipation in 23.8% to 26.1%, and vomiting in 10.6% to 25.3%, compared with lower rates among participants receiving placebo
Philippou, A., et al
The PI3K are capable of generating phosphatidylinositol-3-phosphate, PIP (more informatively designated PtdIns-3-P), phosphatidylinositol-3,4-bisphosphate, PIP 2 (more informatively designated PtdIns-3,4-P 2 ), and phosphatidylinositol-3,4,5-trisphosphate, PIP 3 (more informatively designated PtdIns-3,4,5-P 3 )
They truly want to see you succeed, and it shows
Potential risks include interactions with medications and individual responses to supplementation